Neurocardiovascular pathology in Premanifest and Early Stage Huntington's Disease.

Bellosta Diago E, Pérez-Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez-Horta S, Kulisevsky J, López Del Val J.

Eur J Neurol. 2018 Mar 14. doi: 10.1111/ene.13630. [Epub ahead of print]

Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.

Yusuf IO, Chen HM, Cheng PH, Chang CY, Tsai SJ, Chuang JI, Wu CC, Huang BM, Sun HS, Yang SH.

Free Radic Biol Med. 2018 Nov 2;130:256-266. doi: 10.1016/j.freeradbiomed.2018.10.455. [Epub ahead of print]

Evaluating the current state of the art of Huntington disease research: a scientometric analysis.

Barboza LA, Ghisi NC.

Braz J Med Biol Res. 2018 Jan 11;51(3):e6299. doi: 10.1590/1414-431X20176299.

Huntington disease.

Ghosh R, Tabrizi SJ.

Handb Clin Neurol. 2018;147:255-278. doi: 10.1016/B978-0-444-63233-3.00017-8.

Environment-dependent striatal gene expression in the BACHD rat model for Huntington disease.

Novati A, Hentrich T, Wassouf Z, Weber JJ, Yu-Taeger L, Déglon N, Nguyen HP, Schulze-Hentrich JM.

Sci Rep. 2018 Apr 11;8(1):5803. doi: 10.1038/s41598-018-24243-z.

Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients.

van Roon-Mom WMC, Roos RAC, de Bot ST.

Nucleic Acid Ther. 2018 Apr;28(2):59-62. doi: 10.1089/nat.2018.0720. Epub 2018 Mar 13.

Defective mitochondrial and lysosomal trafficking in chorea-acanthocytosis is independent of Src-kinase signaling.

Glaß H, Pal A, Reinhardt P, Sterneckert J, Wegner F, Storch A, Hermann A.

Mol Cell Neurosci. 2018 Aug 3. pii: S1044-7431(18)30132-5. doi: 10.1016/j.mcn.2018.08.002. [Epub ahead of print]

Predictors of simulated driving performance in Huntington's disease.

Jacobs M, Hart EP, Mejia Miranda Y, Groeneveld GJ, van Gerven JMA, Roos RAC.

Parkinsonism Relat Disord. 2018 Oct 1. pii: S1353-8020(18)30433-4. doi: 10.1016/j.parkreldis.2018.10.002. [Epub ahead of print]

Stem cell transplantation for Huntington's diseases.

Choi KA, Choi Y, Hong S.

Methods. 2018 Jan 15;133:104-112. doi: 10.1016/j.ymeth.2017.08.017. Epub 2017 Sep 1. Review.

Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease.

Wang HB, Loh DH, Whittaker DS, Cutler T, Howland D, Colwell CS.

eNeuro. 2018 Jan 3;5(1). pii: ENEURO.0431-17.2017. doi: 10.1523/ENEURO.0431-17.2017. eCollection 2018 Jan-Feb.

Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis.

Sameni S, Malacrida L, Tan Z, Digman MA.

Sci Rep. 2018 Jan 15;8(1):734. doi: 10.1038/s41598-018-19160-0.

Neurotrophin-3 restores synaptic plasticity in the striatum of a mouse model of Huntington's disease.

Gómez-Pineda VG, Torres-Cruz FM, Vivar-Cortés CI, Hernández-Echeagaray E.

CNS Neurosci Ther. 2018 Feb 17. doi: 10.1111/cns.12824. [Epub ahead of print]

Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.

Wu J, Ryskamp D, Birnbaumer L, Bezprozvanny I.

J Huntingtons Dis. 2018;7(1):35-50. doi: 10.3233/JHD-170266.

Improvement of BDNF signalling by P42 peptide in Huntington's disease.

Couly S, Paucard A, Bonneaud N, Maurice T, Benigno L, Jourdan C, Cohen-Solal C, Vignes M, Maschat F.

Hum Mol Genet. 2018 Jun 1. doi: 10.1093/hmg/ddy207. [Epub ahead of print]

Chorea-acanthocytosis: Homozygous 1-kb deletion in VPS13A detected by whole-genome sequencing.

Walker S, Dad R, Thiruvahindrapuram B, Ullah MI, Ahmad A, Hassan MJ, Scherer SW, Minassian BA.

Neurol Genet. 2018 May 18;4(3):e242. doi: 10.1212/NXG.0000000000000242. eCollection 2018 Jun.